London · Delayed Price · Currency is GBP · Price in GBX Genflow Biosciences Statistics
Total Valuation
LON:GENF has a market cap or net worth of GBP 9.38 million. The enterprise value is 9.10 million.
| Market Cap | 9.38M |
| Enterprise Value | 9.10M |
Important Dates
The last earnings date was Tuesday, December 30, 2025.
| Earnings Date | Dec 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LON:GENF has 493.55 million shares outstanding. The number of shares has increased by 20.39% in one year.
| Current Share Class | 493.55M |
| Shares Outstanding | 493.55M |
| Shares Change (YoY) | +20.39% |
| Shares Change (QoQ) | +9.53% |
| Owned by Insiders (%) | 46.38% |
| Owned by Institutions (%) | 35.14% |
| Float | 258.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -30.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.05 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.29 |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -648.46% and return on invested capital (ROIC) is -405.29%.
| Return on Equity (ROE) | -648.46% |
| Return on Assets (ROA) | -123.70% |
| Return on Invested Capital (ROIC) | -405.29% |
| Return on Capital Employed (ROCE) | 594.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -360,119 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.93% in the last 52 weeks. The beta is 2.30, so LON:GENF's price volatility has been higher than the market average.
| Beta (5Y) | 2.30 |
| 52-Week Price Change | -2.93% |
| 50-Day Moving Average | 1.87 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 50.65 |
| Average Volume (20 Days) | 1,490,814 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.80M |
| Pretax Income | -1.80M |
| Net Income | -1.80M |
| EBITDA | -1.80M |
| EBIT | -1.80M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 279,445 in cash and n/a in debt, with a net cash position of 279,445 or 0.00 per share.
| Cash & Cash Equivalents | 279,445 |
| Total Debt | n/a |
| Net Cash | 279,445 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -303,003 |
| Book Value Per Share | -0.00 |
| Working Capital | -304,531 |
Cash Flow
In the last 12 months, operating cash flow was -1.72 million and capital expenditures 743, giving a free cash flow of -1.72 million.
| Operating Cash Flow | -1.72M |
| Capital Expenditures | 743 |
| Free Cash Flow | -1.72M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:GENF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.39% |
| Shareholder Yield | -20.39% |
| Earnings Yield | -19.20% |
| FCF Yield | -18.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |